Combined immunotherapy with ipilimumab plus nivolumab in metastatic PD-1/PD-L1-refractory Merkel cell carcinoma-a case report

Int J Dermatol. 2024 Feb;63(2):e69-e71. doi: 10.1111/ijd.16986. Epub 2023 Dec 13.

Anna-Sophia Leven¹, Jürgen C Becker^{2

3}, Christoph Pöttgen⁴, Dirk Schadendorf^{1

5

6}, Selma Ugurel^{1

5

6}, Alpaslan Tasdogan^{1

5

6}

¹ Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
² Translational Skin Cancer Research, University Medicine, Essen, Germany.
³ German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ Department of Radiotherapy, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.
⁵ German Cancer Consortium, Partner Site Essen, Essen, Germany.
⁶ National Center for Tumor Diseases (NCT)-West, Campus Essen, & Research Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.

No abstract available

Publication types